Rchr
J-GLOBAL ID:200901030891558109   Update date: Jul. 17, 2024

Numata Kazushi

ヌマタ カズシ | Numata Kazushi
Affiliation and department:
Homepage URL  (1): http://www-user.yokohama-cu.ac.jp/~urasyou/index.htm
Research field  (1): Gastroenterology
Research keywords  (2): 消化器 ,  Gastroenterology
Research theme for competitive and other funds  (8):
  • 1999 - 造影超音波による膵腫瘍の診断
  • 1999 - Diagnosis of Pancreatic Tumor Using Contrast-enhanced Ultrasonography
  • 二酸化炭素動注下のエタノール注入療法
  • 造影超音波による肝細胞癌の診断と治療効果判定
  • 肝腫瘍の診断と治療
Show all
Papers (77):
  • Xian-Yang Qin, Yohei Shirakami, Masao Honda, Shiou-Hwei Yeh, Kazushi Numata, Ya-Yun Lai, Chiao-Ling Li, Feifei Wei, Yali Xu, Kenji Imai, et al. Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International journal of cancer. 2024. 155. 3. 582-594
  • Feiqian Wang, Kazushi Numata, Akihiro Funaoka, Xi Liu, Takafumi Kumamoto, Kazuhisa Takeda, Makoto Chuma, Akito Nozaki, Litao Ruan, Shin Maeda. Establishment of nomogram prediction model of contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for vessels encapsulating tumor clusters pattern of hepatocellular carcinoma. Bioscience trends. 2024
  • Satoshi Kobayashi, Taito Fukushima, Makoto Ueno, Makoto Chuma, Kazushi Numata, Kota Tsuruya, Yoshitaka Arase, Shunji Hirose, Tatehiro Kagawa, Nobuhiro Hattori, et al. Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver. 2024. 44. 6. 1343-1350
  • Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Satoshi Shimizu, Yasushi Kojima, Atsushi Hiraoka, et al. Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD. Liver cancer. 2024. 13. 2. 193-202
  • Josep M Llovet, Masatoshi Kudo, Philippe Merle, Tim Meyer, Shukui Qin, Masafumi Ikeda, Ruocai Xu, Julien Edeline, Baek-Yeol Ryoo, Zhenggang Ren, et al. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial. The Lancet Oncology. 2023. 24. 12. 1399-1410
more...
MISC (139):
more...
Books (6):
  • ソラフェニブ不応の肝細胞癌に対するレゴラフェニブの7症例.
    アークメディア社 2017
  • 一歩進んだ腹部エコーの使い方
    文光堂 2016
  • 肝細胞癌に対する造影エコーガイド下経皮的治療
    消化器疾患の造影エコーUp Date 2003
  • 膵腫瘍の造影超音波
    消化器造影超音波マニュアル 真興交易(株)医書出版部 2001
  • Contrast-enhanced Harmonic Gray-scale Imaging の門脈相の有用性:肝腫瘍の鑑別診断と進行肝細胞癌の治療効果判定
    消化器造影超音波マニュアル 真興交易(株)医書出版部 2001
more...
Education (2):
  • - 1985 Shinshu University School of Medicine Department of Medicine
  • - 1985 Shinshu University Faculty of Medicine
Professional career (1):
  • (BLANK)
Work history (3):
  • 1995 - 2004 横浜市立大学医学部 助手
  • 1995 - 2003 Research Associate, Yokohama City University
  • School of Medicine
Awards (4):
  • 2018 - Journal of Medical Ultrasonics. Year of the article 2018 Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
  • 2017 - Journal of Medical Ultrasonics. Article of the year 2017
  • 2016/03 - Abdominal imaging Year of the article 2015
  • 2002 - 社団法人日本超音波医学会第4回奨励賞
Association Membership(s) (5):
日本肝臓学会 ,  消化器内視鏡学会 ,  日本消化器病学会 ,  日本超音波学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page